Statistics of DOUBLE-BLIND STUDY OF TOCILIZUMAB plus METHOTREXATE VERSUS TOCILIZUMAB plus PLACEBO IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE PRIOR METHOTREXATE: PROGRESSION OF STRUCTURAL DAMAGE, QUALITY OF LIFE AND PHYSICAL FUNCTION AT 24 WEEKS
